Cryoport, Inc. announced that its industry leading cryogenic logistics solutions, including cryogenic shipping, logistics support and chain of condition monitoring, are supporting Tissue Solutions (Tissue Solutions) as it transports products from their global network of more than 100 locations. Tissue Solutions is a leading supplier of human bio specimens to the pharmaceutical and biotech industries worldwide, specializing in the supply of high quality, ethically sourced human tissue and bio fluids for clinical trial programs.

Tissue Solutions is utilizing Cryoport's logistics management platform, proprietary Cryoport Express dry vapor dewars and advanced Smart Pak II condition monitoring systems to ship isolated human cells and cryopreserved cell lines from international collection sites to clients across the globe. The Smart Pak II Condition Monitoring System is engineered to work in tandem with Cryoport's data management platform, the Cryoportal, which provides automated alerts regarding changes in required conditions, including deviations from estimated transit times, temperature excursions, potential temperature excursions, as well as shipper condition and openings. Cryoport's custom end-to-end solutions provides Tissue Solutions' cell lines with the most advanced cryogenic logistics solution anywhere including constant monitoring during the entire logistics process.

Morag McFarlane, CEO of Tissue Solutions stated, "We use Cryoport to ship isolated human cells and cryopreserved cell lines, including PBMCs and other immune cell subsets. Shipping at cryogenic temperatures with Cryoport's solution offers our clients the best option to minimize temperature fluctuations which can have a detrimental impact on cell integrity. Also, Cryoport's custom solutions significantly broaden our reach and the number of sites we can offer to our clients. Further, it affords our clients the option to select samples based on a wide range of specific donor demographic characteristics or screen multiple lots to find the sample that works best for their research, ensuring they get the specific samples they need, and are not restricted geographically."

Jerrell Shelton, CEO of Cryoport, said, "Cryoport is proud to be supporting Tissue Solutions, which is a leading supplier of ethically sourced human bio specimens. Tissue Solutions' services provide an indispensable link for a number of pharmaceutical and biotech companies for preclinical research and safety testing of drugs. Tissue Solutions depends on the support that only Cryoport can bring in supporting its highly successful services with Cryoport's advanced cryogenic logistics expertise and technology including our highly engineered and validated cryogenic cold chain shippers accompanied by crucial real-time and archived information."